Understanding primary packaging material options and selecting optimum container closure systems for lifecycle containment is important to minimize risk and development costs.
The strong market growth in injectable therapeutics, primarily driven by biological proteins and vaccines, has resulted in novel innovative drug packaging presentations and container closure systems. Such systems, including prefillable syringes, are available and being developed for improved drug-package stability, to eliminate silicone oil and tungsten known to cause protein aggregation in prefillable syringes. These container closure systems are suitable for low temperature storage conditions.
Tibor Hlobik will present “Innovations in Container Closure Systems and New Industry Technologies” at the PharmaEd Resources Container Closure Systems 2010 “Strategies for Selection, Compliance, and Mitigation of Extractables and Leachables Challenges” conference to be held on January 25-26,2010, at the Radisson Warwick Hotel in Philadelphia, Pennsylvania.
This discussion will cover and include case examples in support of:
- Standards and selection for vial and prefillable syringe components
- Container Closure Solutions for sensitive protein drug products
- Functionality considerations for injectable delivery systems
- Combination products for market differentiation and improved compliance for injectable combination products.
To learn more or to register to attend, visit: http://www.pharmaedresources.com/
Tibor Hlobik, Associate Director, Marketing for PFS Technologies
Tibor.Hlobik@westpharma.com
610-594-3126